Literature DB >> 18533066

Screening for dementia in primary care: a review of the use, efficacy and quality of measures.

A Milne1, A Culverwell, R Guss, J Tuppen, R Whelton.   

Abstract

BACKGROUND: Despite evidence that early identification of dementia is of growing policy and practice significance in the U.K., limited work has been done on evaluating screening measures for use in primary care. The aim of this paper is to offer a clinically informed synthesis of research and practice-based evidence on the utility, efficacy and quality of dementia screening measures.
METHOD: The study has three elements: a review of research literature, a small-scale survey of measures employed in three primary care trusts, and a systematic clinical evaluation of the most commonly used screening instruments. The study integrates data from research and clinical sources.
RESULTS: The General Practitioner Assessment of Cognition (GPCOG), the Memory Impairment Screen (MIS), and the Mini-Cognitive Assessment Instrument (Mini-Cog) were found to be brief, easy to administer, clinically acceptable, effective, and minimally affected by education, gender, and ethnicity. All three have psychometric properties similar to the Mini-mental State Examination (MMSE).
CONCLUSIONS: Although the MMSE is widely used in the U.K., this project identifies the GPCOG, MIS and Mini-Cog as clinically and psychometrically robust and more appropriate for routine use in primary care. A coherent review of evidence coupled with an indepth evaluation of screening instruments has the potential to enhance ability and commitment to early intervention in primary care and, as part of a wider educational strategy, improve the quality and consistency of dementia screening.

Entities:  

Mesh:

Year:  2008        PMID: 18533066     DOI: 10.1017/S1041610208007394

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  51 in total

1.  The effect of cognitive impairment on the accuracy of the presenting complaint and discharge instruction comprehension in older emergency department patients.

Authors:  Jin H Han; Suzanne N Bryce; E Wesley Ely; Sunil Kripalani; Alessandro Morandi; Ayumi Shintani; James C Jackson; Alan B Storrow; Robert S Dittus; John Schnelle
Journal:  Ann Emerg Med       Date:  2011-01-26       Impact factor: 5.721

2.  A view from the USA on the Alzheimer's disease international position paper.

Authors:  L Z Rubenstein
Journal:  J Nutr Health Aging       Date:  2010-02       Impact factor: 4.075

3.  In patients suspected of cognitive decline, what is the most accurate in-office screening instrument to determine if there is dementia needing further evaluation and management?

Authors:  Jamie Quitoriano; Robert M Hamm
Journal:  J Okla State Med Assoc       Date:  2017 Sep-Oct

4.  Screening for cognitive impairment, Alzheimer's disease and other dementias: opinions of European caregivers, payors, physicians and the general public.

Authors:  J Bond; N Graham; A Padovani; J Mackell; S Knox; J Atkinson
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

Review 5.  New developments in the diagnosis of dementia.

Authors:  Gerhard W Eschweiler; Thomas Leyhe; Stefan Klöppel; Michael Hüll
Journal:  Dtsch Arztebl Int       Date:  2010-10-01       Impact factor: 5.594

6.  Relationship of dementia screening tests with biomarkers of Alzheimer's disease.

Authors:  James E Galvin; Anne M Fagan; David M Holtzman; Mark A Mintun; John C Morris
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

7.  A social dancing pilot intervention for older adults at high risk for Alzheimer's disease and related dementias.

Authors:  Helena M Blumen; Emmeline Ayers; Cuiling Wang; Anne F Ambrose; Joe Verghese
Journal:  Neurodegener Dis Manag       Date:  2020-08-03

Review 8.  Improving dementia care: the role of screening and detection of cognitive impairment.

Authors:  Soo Borson; Lori Frank; Peter J Bayley; Malaz Boustani; Marge Dean; Pei-Jung Lin; J Riley McCarten; John C Morris; David P Salmon; Frederick A Schmitt; Richard G Stefanacci; Marta S Mendiondo; Susan Peschin; Eric J Hall; Howard Fillit; J Wesson Ashford
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

9.  Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.

Authors:  Yuki Matsuura; Masashi Ueda; Yusuke Higaki; Kohei Sano; Hideo Saji; Shuichi Enomoto
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

10.  Assessment scales in dementia.

Authors:  Bart Sheehan
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.